Business Description
Panion & Bf Biotech Inc
NAICS : 325412
SIC : 2834
ISIN : TW0001760007
Description
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. It is engaged in research and development of pharmaceuticals and new drugs. It focuses on pharmaceuticals, cosmeceuticals, nutraceuticals, and medical devices sectors. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has two geographic segments Taiwan segment and China, Hong Kong, and Macau segment. It generate majority of the revenue from Taiwan segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.74 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | 2.08 | |||||
| Interest Coverage | 13.72 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.72 | |||||
| Beneish M-Score | -2.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.9 | |||||
| 3-Year EBITDA Growth Rate | 21.4 | |||||
| 3-Year EPS without NRI Growth Rate | 31.1 | |||||
| 3-Year FCF Growth Rate | 69.1 | |||||
| 3-Year Book Growth Rate | 11.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.02 | |||||
| 9-Day RSI | 35.59 | |||||
| 14-Day RSI | 37.26 | |||||
| 6-1 Month Momentum % | 5.07 | |||||
| 12-1 Month Momentum % | -30.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.41 | |||||
| Quick Ratio | 0.89 | |||||
| Cash Ratio | 0.51 | |||||
| Days Inventory | 227.77 | |||||
| Days Sales Outstanding | 40.9 | |||||
| Days Payable | 54.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.07 | |||||
| Dividend Payout Ratio | 2.27 | |||||
| 3-Year Dividend Growth Rate | 4.1 | |||||
| Forward Dividend Yield % | 2.07 | |||||
| 5-Year Yield-on-Cost % | 2.07 | |||||
| 3-Year Average Share Buyback Ratio | -3.3 | |||||
| Shareholder Yield % | -0.03 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.78 | |||||
| Operating Margin % | 8.28 | |||||
| Net Margin % | 4.1 | |||||
| FCF Margin % | -0.2 | |||||
| ROE % | 4.05 | |||||
| ROA % | 2.46 | |||||
| ROIC % | 3.11 | |||||
| ROC (Joel Greenblatt) % | 9.52 | |||||
| ROCE % | 8.52 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 108.76 | |||||
| PE Ratio without NRI | 110 | |||||
| Shiller PE Ratio | 55.42 | |||||
| Price-to-Owner-Earnings | 127.54 | |||||
| PEG Ratio | 15.07 | |||||
| PS Ratio | 4.41 | |||||
| PB Ratio | 4.34 | |||||
| Price-to-Tangible-Book | 4.37 | |||||
| Price-to-Operating-Cash-Flow | 46.97 | |||||
| EV-to-EBIT | 47.16 | |||||
| EV-to-EBITDA | 24.23 | |||||
| EV-to-Revenue | 4.51 | |||||
| EV-to-FCF | -2227.31 | |||||
| Price-to-Projected-FCF | 3.72 | |||||
| Price-to-DCF (Earnings Based) | 7.68 | |||||
| Price-to-Peter-Lynch-Fair-Value | 19.6 | |||||
| Price-to-Graham-Number | 4.62 | |||||
| Price-to-Net-Current-Asset-Value | 54.38 | |||||
| Earnings Yield (Greenblatt) % | 2.12 | |||||
| FCF Yield % | -0.05 | |||||
| Forward Rate of Return (Yacktman) % | 6.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Panion & Bf Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,881.875 | ||
| EPS (TTM) (NT$) | 0.89 | ||
| Beta | -0.3 | ||
| Volatility % | 26.52 | ||
| 14-Day RSI | 37.26 | ||
| 14-Day ATR (NT$) | 2.506735 | ||
| 20-Day SMA (NT$) | 101.835 | ||
| 12-1 Month Momentum % | -30.06 | ||
| 52-Week Range (NT$) | 90.3 - 168.5 | ||
| Shares Outstanding (Mil) | 85.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Panion & Bf Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Panion & Bf Biotech Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Panion & Bf Biotech Inc Frequently Asked Questions
What is Panion & Bf Biotech Inc(TPE:1760)'s stock price today?
The current price of TPE:1760 is NT$96.80. The 52 week high of TPE:1760 is NT$168.50 and 52 week low is NT$90.30.
When is next earnings date of Panion & Bf Biotech Inc(TPE:1760)?
The next earnings date of Panion & Bf Biotech Inc(TPE:1760) is .
Does Panion & Bf Biotech Inc(TPE:1760) pay dividends? If so, how much?
The Dividend Yield %  of Panion & Bf Biotech Inc(TPE:1760) is 2.07% (As of Today), Highest Dividend Payout Ratio of Panion & Bf Biotech Inc(TPE:1760) was 4.49. The lowest was 0.1. And the median was 0.71. The  Forward Dividend Yield % of Panion & Bf Biotech Inc(TPE:1760) is 2.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers